MNKDSMALL

MannKind Corporation

HealthcareBiotechnology
$3.94
$0.00(+0.51%)
52W$2.23
$6.51
Updated Jun 22, 02:00 AM
RSI64
RS Rating51/99
Beta1.14
Volatility73%
F-Score4/9
Mkt Cap$1.2B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

MannKind Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 51), indicating performance broadly in line with the market. Earnings contraction of 231% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
51
out of 99
Average
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.14
vs S&P 500
ABOVE MKT
52W Position
40%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.21
50 SMA > 100 SMA$3.55
100 SMA > 150 SMA$4.23
150 SMA > 200 SMA$4.53

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.61+9.22%ABOVE
50 SMA$3.21+22.90%ABOVE
100 SMA$3.55+11.08%ABOVE
150 SMA$4.23-6.81%BELOW
200 SMA$4.53-13.09%BELOW

Price Performance

1D+0.5%
1W+5.1%
1M+31.8%
3M+51.0%
6M-34.0%
YTD-29.6%
1Y+3.4%
3Y-0.7%
52-Week Trading Range40% from low
$3.94
52W Low$2.23
52W High$6.51

Technical Indicators

RSI (14)BULLISH
63.8
305070
Setup ScoreCOOL
2/10
Base depth: 52.3%

Risk Profile

Beta
1.14
52W Vol
73%
ATR
$0.22
Max DD (1Y)
-63%

Volume Analysis

Today
11.62M
50D Avg
5.54M
Vol Ratio
2.10x
Liquidity
MODERATE

Earnings Momentum

Q2'25+128%
$0.00
Q3'25-37%
$0.03
Q4'25-292%
$-0.05
Q1'26-231%
$-0.05
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+39.89%
3 Years:+51.80%
TTM:+21.23%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-175.43%

Stock Price CAGR

10 Years:-2.74%
5 Years:-1.55%
3 Years:-0.67%
1 Year:+3.41%

Return on Equity

10Y Avg:
5Y Avg:
3Y Avg:
Last Year:

Key Metrics

Market Cap$1.2B
Gross Margin82.5%
Net Margin1.7%
Piotroski F-Score4/9

Frequently Asked Questions

Is MNKD in an uptrend right now?

MNKD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is MNKD overbought or oversold?

MNKD's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.

Is MNKD outperforming the market?

MNKD has a Relative Strength (RS) Rating of 51 out of 99. MNKD is performing about average compared to the market.

Where is MNKD in its 52-week range?

MNKD is trading at $3.94, which is 61% of its 52-week high ($6.51) and 40% above its 52-week low ($2.23).

How volatile is MNKD?

MNKD has a Beta of 1.14 and 52-week volatility of 73%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.